XML 39 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Nov. 15, 2016
Jul. 31, 2016
Personnel cost $ 158,140 $ 41,991      
Due to related party 200,333   $ 83,166    
Warrants issued for remaining debt amount 178,572        
Chairman Of Board [Member] | Line Letter [Member]          
Line of credit current borrowing capacity     $ 250,000 $ 540,000  
Trieu [Member] | Line Letter [Member]          
Line of credit 475,064     250,000  
Line of credit interest 5,450        
Trieu [Member] | Line Letter [Member] | April 4, 2017 [Member]          
Line of credit current borrowing capacity $ 500,000        
Number of common stock issued for merger 5,255,354        
IthenaPharma Inc [Member] | Investor [Member]          
Debt instrument face amount         $ 50,000
Debt instrument interest rate         3.00%
Shares issued price per share         $ 1.80
Related Party [Member] | IthenaPharma Inc [Member]          
Due to related party       $ 5,375  
Autotelic [Member]          
Billed expenses $ 213,103 $ 72,231      
Master Services Agreement [Member]          
Ownership interest 10.00%        
Proceeds from common or preferred stock, gross $ 10,000,000        
Provider services description After the Equity Financing Date, the Company shall pay Autotelic a cash amount equal to the actual labor cost plus 100% mark up of provided services and 20% mark up of provided services by third party contractors or material used in connection with the performance of the contracts, including but not limited to clinical trial, non-clinical trial, Contract Manufacturing Organizations (“CMO”), U.S. Food & Drug Administration (“FDA”) regulatory process, Contract Research Organizations (“CRO”) and Chemistry and Manufacturing Controls (“CMC”).        
Master Services Agreement [Member] | Related Party [Member]          
Service provider percentage 20.00%